Tonix plunges 68% after PTSD drug failure
July 30, 2018Research and Development, Sales and Marketing PTSD, Tonmya, pharma, tonix
Tonix Pharmaceuticals has announced that it has terminated its Phase 3 study of Tonmya (cyclobenzaprine HCl sublingual tablets) in military-related …
Army to ferry medicines in case of no-deal Brexit
July 30, 2018Sales and Marketing UK, army, brexit, medicines, pharma, politics, supply chains
Ministers have established plans to use the army to deliver medicines, food and fuel in the event of a no-deal …
Amgen announces resignation of two top executives
July 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Anthony C Cooper, R&D, biotech, retire, sean harper
Amgen’s head of R&D, Dr Sean Harper, has announced that he is retiring from his current position as Executive Vice …
Top Ten most popular articles on Pharmafile.com this week
July 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra
With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …
Those at risk of HIV to be offered PrEP drugs in England and Northern Ireland
July 27, 2018Medical Communications AIDS, England, HIV, PrEP, Terrence Higgins Trust
Those at risk of contracting HIV will now be offered PrEP drugs in England and Northern Ireland through a programme …
Takeda’s Alunbrig topples Pfizer’s Xalkori in ALK-positive lung cancer
July 27, 2018Medical Communications, Research and Development Alunbrig, Cancer, NSCLC, Pfizer, Takeda, Xalkori, lung cancer, pharma
Takeda has unveiled new Phase 3 data showing that its tyrosine kinase inhibitor (TKI) Alunbrig (brigatinib) not only met its …
Landlord demands EMA pay £500m for Canary Wharf lease
July 27, 2018Medical Communications Canary Wharf, EMA, Litigation, London, amsterdam, court
A British landlord is taking the European Medicines Agency (EMA) to court over a £500 million bill for unpaid rent. …
Cannabis-derived medicinal products to become available in UK
July 26, 2018Medical Communications cannabis, law, medicinal marijuana, prescription, sajid javid, schedule drugs, uk politics
Home Secretary Sajid Javid has announced that cannabis derived medicinal products will be made available on prescription “by the autumn” …
GSK forges $300m partnership with 23andMe to boost preclinical R&D
July 26, 2018Research and Development 23andME, GSK, GlaxoSmithKline, collaboration, genetics, pharma
In a bid to supercharge its drug discovery efforts, GlaxoSmithKline has sealed a $300 million deal with personal genomics and …
Merck KGaA announces new Senior Vice President, Head of Global Affairs
July 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Maria Rivas, Germany, Merck, Merck KGaA, research and development
Merck KGaA has announced the appointment of Dr Maria Rivas as Senior Vice President, Head of Global Affairs. Dr Rivas, …
Gilead’s CEO and Chairman to both step down before year’s end
July 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma
Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
AstraZeneca announces price freezes while earnings drop by 28%
July 26, 2018Business Services, Sales and Marketing AstraZeneca, Trump, price freezes, price hikes
The Anglo-Swedish drug maker AstraZeneca has joined Pfizer and others in halting price hikes until the end of 2018. AstraZeneca …
Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials
July 26, 2018Research and Development Alzheimer's disease, BAN2401, Biodgen, Eisai, phase 2, research
An experimental drug developed by the Massachusetts-based multinational Biogen and their Japanese partner Eisai has been shown to significantly slow …
NHS to stockpile drugs in preparation for no-deal Brexit
July 25, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, brexit, government, pharma, stockpiling
Secretary of State for Health and Social Care, Matt Hancock, has said that the NHS is preparing to stockpile medicines …
FDA approves first endometriosis pain management drug in a decade
July 25, 2018Research and Development, Sales and Marketing AbbVie, FDA, Neurocrine Biosciences, endometriosis, pharma
The FDA has confirmed its approval of AbbVie and Neurocrine Biosciences’ Orilissa (elagolix), a nonpeptide small molecule gonadotropin-releasing hormone (GnRH) …
HPV vaccine to be given to boys in England
July 25, 2018Research and Development Cancer, HPV, infectious disease, sexually transmitted diseases, vaccines, virus
The government has announced that boys in England aged 12 and 13 will be vaccinated against Human Papilloma Virus (HPV) …
Pfizer to build $465m sterile injectable plant in Michigan
July 25, 2018Manufacturing and Production, Research and Development Michigan, Pfizer, US, manufacturing, pharma
Pfizer has unveiled plans to invest $465 million to build a new sterile injectables plant in Portage, Michigan, saying that …
More antidepressants being prescribed to children in UK
July 25, 2018Research and Development antidepressants, children, mental health, prescription, young people
Figures have revealed a trend towards an increased number of prescriptions for antidepressants for children in England, Scotland, and Northern …
Eleven babies dead after Dutch viagra trial
July 25, 2018Research and Development Netherlands, clinical trial, deaths, premature, viagra
A trial of the drug sildenafil, commonly sold under the brand name Viagra, has been halted immediately after the death …
Teva Romania announces new general manager
July 24, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Israeli multinational Teva Pharmaceuticals have announced the appointment of Stana Moisescu as the General Director of Teva Romania, the company’s …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
